Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.3 CHF | +0.28% | -2.82% | +42.04% |
04-26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
04-25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Evolution of the average Target Price on Cosmo Pharmaceuticals N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cosmo Pharmaceuticals N.V.
Berenberg Bank | |
Research Capital |
EPS Revisions
- Stock Market
- Equities
- COPN Stock
- Consensus Cosmo Pharmaceuticals N.V.